Skip to main content
. 2011 May 5;27(1):166–173. doi: 10.1093/ndt/gfr218

Table 2.

Hazard ratios for incident stroke symptoms associated with level of eGFRa

Level of eGFR, mL/min/1.73m2
≥90 (n = 9516) 60–89 (n = 9152) 45–59 (n = 1335) <45 (n = 591) P-trend
Any stroke symptom
    Hazard ratio 1 1 (ref) 1.01 (0.93–1.11) 1.26 (1.08–1.46) 1.40 (1.15–1.70) <0.001
    Hazard ratio 2 1 (ref) 1.01 (0.92–1.11) 1.18 (1.01–1.38) 1.21 (0.99–1.48) 0.017
Symptom—sudden weakness
    Hazard ratio 1 1 (ref) 1.09 (0.92–1.29) 1.49 (1.13–1.95) 1.41 (0.97–2.07) 0.004
    Hazard ratio 2 1 (ref) 1.08 (0.91–1.28) 1.39 (1.06–1.84) 1.25 (0.85–1.83) 0.033
Symptom—sudden numbness
    Hazard ratio 1 1 (ref) 1.03 (0.9–1.18) 1.29 (1.02–1.65) 1.45 (1.05–1.99) 0.010
    Hazard ratio 2 1 (ref) 1.03 (0.9–1.19) 1.22 (0.96–1.56) 1.23 (0.89–1.71) 0.095
Symptom—sudden painless loss of vision in one or both eyes
    Hazard ratio 1 1 (ref) 1.13 (0.94–1.36) 1.33 (1.00–1.78) 1.41 (0.96–2.07) 0.019
    Hazard ratio 2 1 (ref) 1.16 (0.96–1.40) 1.29 (0.96–1.72) 1.24 (0.84–1.84) 0.076
Symptom—sudden loss of half vision
    Hazard ratio 1 1 (ref) 1.14 (0.88–1.47) 1.22 (0.80–1.86) 1.88 (1.16–3.04) 0.025
    Hazard ratio 2 1 (ref) 1.13 (0.87–1.46) 1.10 (0.72–1.69) 1.57 (0.96–2.54) 0.155
Symptom—suddenly lost ability to understand people
    Hazard ratio 1 1 (ref) 0.98 (0.79–1.20) 1.44 (1.08–1.93) 1.59 (1.10–2.31) 0.002
    Hazard ratio 2 1 (ref) 0.96 (0.78–1.18) 1.32 (0.98–1.78) 1.37 (0.94–2.00) 0.024
Symptom—suddenly lost ability to express self verbally or in writing
    Hazard ratio 1 1 (ref) 1.03 (0.84–1.27) 1.42 (1.04–1.94) 1.58 (1.05–2.36) 0.007
    Hazard ratio 2 1 (ref) 1.03 (0.83–1.27) 1.35 (0.98–1.86) 1.44 (0.96–2.18) 0.025
a

Ref, reference category. Numbers in table are hazard ratio (95% CI). Hazard ratio 1 is adjusted for age, race, sex and geographic region. Hazard ratio 2 is adjusted for age, race, sex, geographic region, education, household income, current smoking, alcohol consumption, BMI, systolic blood pressure, antihypertensive medication use, dyslipidemia, diabetes and elevated C-reactive protein.